Clinical trial
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
NCT03233191 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- September 28, 2017
- Completion date
- December 31, 2029
- Enrollment
- 108,508 (estimated)
- Sites
- 149
Conditions
As the registry lists them; a condition with its own page is linked.
breast screening